ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 225,80
0,20%
Dow Jones
39 558,11
0,32%
DAX
18 716,42
-0,12%
Brent Oil
82,55
-0,79%
Bitcoin
61 589,33
-2,09%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Coya Therapeutics Inc (COYA)

  7. Coya Therapeutics Inc (COYA) Actualités

COYA Coya Therapeutics Inc

8,25
0,17 (2,10%)
Après les heures de négociation
Dernière mise à jour : 22:30:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Coya Therapeutics Inc COYA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,17 2,10% 8,25 22:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
8,06 8,06 8,4799 8,25 8,08
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/5/202422:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:20EDGAR2Form 8-K - Current report
09/5/202422:10BWCoya Therapeutics Provides a Corporate Update and Reports..
08/5/202423:21EDGAR2Form 8-K - Current report
26/4/202414:15BWCoya Therapeutics Presents Updated ALS Biomarker Data at the..
22/4/202414:15BWCoya Therapeutics to Participate in the Mizuho Neuroscience..
18/4/202414:15BWCoya Therapeutics to Participate in the 3rd Annual ALS Drug..
08/4/202414:15BWCoya Therapeutics Scientific Advisory Board Chairman Dr...
19/3/202413:15BWCoya Therapeutics Provides a Corporate Update and Reports..
12/3/202414:00BWCoya Therapeutics to Participate in BTIG Fireside Discussion
12/3/202413:00BWCoya Therapeutics Presents ALS Biomarker Data at Society of..
06/3/202414:15BWCoya Therapeutics Presents Biomarker Data on..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:15BWCoya Therapeutics to Present Data on Immune System and..
22/2/202414:15BWCoya Therapeutics to Present Novel Biomarker Survival Data..
21/2/202414:15BWCoya Therapeutics Issues Letter to Stockholders Highlighting..
13/2/202414:15BWCoya Therapeutics Licenses Intellectual Property Rights for..
03/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202414:15BWCoya Therapeutics SAB Chairman Dr. Stanley Appel, M.D...
20/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202414:15EDGAR2Form 8-K - Current report
18/1/202414:15BWCoya Therapeutics to Participate in Upcoming Chardan Biotech..
16/1/202422:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/1/202414:15BWCoya Therapeutics Announces Pipeline Expansion of COYA 302..
16/1/202410:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
16/1/202409:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
05/1/202414:00BWCoya Therapeutics Announces Successful Pre-IND and Type C..
04/1/202422:46EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202315:46EDGAR2Form D - Notice of Exempt Offering of Securities
20/12/202314:35EDGAR2Form 8-K - Current report
20/12/202314:30BWMr. Wilbur L. Ross, Former United States Secretary of..
13/12/202314:00BWCoya Therapeutics’ CEO Dr. Howard Berman’s Letter to..
12/12/202314:00BWCoya Therapeutics Announces Closing of $26.5 Million Private..
06/12/202313:30EDGAR2Form 8-K - Current report
06/12/202313:05BWCoya Therapeutics Announces $26.5 Million Private Placement
06/12/202313:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
08/11/202315:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:03EDGAR2Form 8-K - Current report
08/11/202315:00BWCoya Therapeutics, Inc. Provides Business Update and Reports..
27/10/202315:00BWCoya Announces Acceptance of Oral Presentation, “Regulatory..
09/10/202314:00BWCoya Therapeutics (Coya) Announces Completion of Enrollment..
05/10/202315:00BWCoya Therapeutics Presents New Experimental Data Supporting..
03/10/202315:00BWCoya Therapeutics Announces the Presentation of Human..
27/9/202315:00BWCoya Therapeutics to Present at the LD Micro Investor..
22/9/202315:00BWCoya Therapeutics Licenses Exclusive Worldwide rights to..
07/9/202315:15BWCoya Therapeutics Successfully Engineers Regulatory T Cell..
31/8/202314:00BWCoya Therapeutics Announces Publication of Potential Novel..

Dernières Valeurs Consultées

NASDAQ
COYA
Coya Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés